Literature DB >> 25913294

Influence of probiotic administration on the fecal microbiota in diarrhea-predominant irritable bowel syndrome.

C Subramanyam1, Nitesh Pratap, Prasad Gandham, Rupjyothi Talukdar, M Sasikala, H V V Murthy, D Nageshwar Reddy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25913294     DOI: 10.1007/s12664-015-0545-8

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


× No keyword cloud information.
  4 in total

Review 1.  A role for the gut microbiota in IBS.

Authors:  Stephen M Collins
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-22       Impact factor: 46.802

2.  Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.

Authors:  Siew Chien Ng; Emma F C Lam; Tommy T Y Lam; Yawen Chan; Wendy Law; Pete C H Tse; Michael A Kamm; Joseph J Y Sung; Francis K L Chan; Justin C Y Wu
Journal:  J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 4.029

3.  Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.

Authors:  C Tana; Y Umesaki; A Imaoka; T Handa; M Kanazawa; S Fukudo
Journal:  Neurogastroenterol Motil       Date:  2009-11-10       Impact factor: 3.598

4.  Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  I M Carroll; T Ringel-Kulka; J P Siddle; Y Ringel
Journal:  Neurogastroenterol Motil       Date:  2012-02-20       Impact factor: 3.598

  4 in total
  2 in total

1.  The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study.

Authors:  Seok-Hoon Lee; Nam-Seok Joo; Kwang-Min Kim; Kyu-Nam Kim
Journal:  Gastroenterol Res Pract       Date:  2018-12-06       Impact factor: 2.260

2.  Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis.

Authors:  Ratnakar Shukla; Ujjala Ghoshal; Prabhat Ranjan; Uday C Ghoshal
Journal:  J Neurogastroenterol Motil       Date:  2018-10-01       Impact factor: 4.924

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.